Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Therapeutic Advances in Infectious Disease
|
August 29, 2014
Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports
Jules C Hancox, Mehrul Hasnain, W Victor R Vieweg, et al.
Expert Review of Cardiovascular Therapy
|
October 24, 2013
Torsades de pointes following clarithromycin treatment
Michael Gysel, W Victor R Vieweg, Mehrul Hasnain, et al.
Bipolar Disorders
|
March 18, 2006
Diffusion-weighted magnetic resonance imaging of white matter in bipolar disorder: a pilot study
William T Regenold, Christopher A D'Agostino, Narayanan Ramesh, et al.
Southern Medical Journal
|
March 25, 2008
The risk of overweight in children and adolescents with major mental illness
Mehrul Hasnain, W Victor R Vieweg, John M Hettema, et al.
Therapeutic Advances in Infectious Disease
|
August 29, 2014
Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports
W Victor R Vieweg, Jules C Hancox, Mehrul Hasnain, et al.
The American Journal of Medicine
|
June 30, 2009
Pharmacological management of psychosis in elderly patients with parkinsonism
Mehrul Hasnain, W Victor R Vieweg, Mark S Baron, et al.
Primary Care Diabetes
|
December 17, 2008
Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications
Mehrul Hasnain, W Victor R Vieweg, Sonja K Fredrickson, et al.
The American Journal of Medicine
|
June 25, 2011
Depression, stress, and heart disease in earthquakes and Takotsubo cardiomyopathy
W Victor R Vieweg, Mehrul Hasnain, Briana Mezuk, et al.
Drugs & Aging
|
November 26, 2009
Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly
W Victor R Vieweg, Mark A Wood, Antony Fernandez, et al.
The American Journal of Medicine
|
July 4, 2012
Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?
W Victor R Vieweg, Mehrul Hasnain, Robert H Howland, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Therapeutic Advances in Infectious Disease
|
August 29, 2014
Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports
Jules C Hancox, Mehrul Hasnain, W Victor R Vieweg, et al.
Expert Review of Cardiovascular Therapy
|
October 24, 2013
Torsades de pointes following clarithromycin treatment
Michael Gysel, W Victor R Vieweg, Mehrul Hasnain, et al.
Bipolar Disorders
|
March 18, 2006
Diffusion-weighted magnetic resonance imaging of white matter in bipolar disorder: a pilot study
William T Regenold, Christopher A D'Agostino, Narayanan Ramesh, et al.
Southern Medical Journal
|
March 25, 2008
The risk of overweight in children and adolescents with major mental illness
Mehrul Hasnain, W Victor R Vieweg, John M Hettema, et al.
Therapeutic Advances in Infectious Disease
|
August 29, 2014
Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports
W Victor R Vieweg, Jules C Hancox, Mehrul Hasnain, et al.
The American Journal of Medicine
|
June 30, 2009
Pharmacological management of psychosis in elderly patients with parkinsonism
Mehrul Hasnain, W Victor R Vieweg, Mark S Baron, et al.
Primary Care Diabetes
|
December 17, 2008
Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications
Mehrul Hasnain, W Victor R Vieweg, Sonja K Fredrickson, et al.
The American Journal of Medicine
|
June 25, 2011
Depression, stress, and heart disease in earthquakes and Takotsubo cardiomyopathy
W Victor R Vieweg, Mehrul Hasnain, Briana Mezuk, et al.
Drugs & Aging
|
November 26, 2009
Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly
W Victor R Vieweg, Mark A Wood, Antony Fernandez, et al.
The American Journal of Medicine
|
July 4, 2012
Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?
W Victor R Vieweg, Mehrul Hasnain, Robert H Howland, et al.
Page
of 5